Related Image: American Chemical Society Weekly PressPac Oct. 15, 2008 |
(Date:12/2/2009)...the National Institute of Health, 40 percent to 45...ady have some stage of diabetic retinopathy. Diab...eaky blood vessels, is a major cause of blindness ...red diabetic complications. In fact, up to 80 per...ars or more will experience some form of diabetic ...
(Date:12/1/2009)...ewswire/ -- GestureTek Inc. today announced the la...e, plug and play interactive projection display sy...touring promotions. GestureTek is the inventor and...ture recognition technology for interactive displa...uaranteed for quality, the CUBE has TUV, CE, CSA a...
(Date:12/1/2009)...en awarded a U.S. Air Force Center of Excellence t...adaptive materials, and to develop tools to optimi...ighter. , The $10.5 million Center, known as th...s and Improved Cognition (BIONIC) center, is being...fessors in Georgia Tech,s School of Materials Scie...
Breaking Biology News(10 mins):Study shows pine bark improves circulation, swelling and visual acuity in early diabetic retinopathy 2Study shows pine bark improves circulation, swelling and visual acuity in early diabetic retinopathy 3GestureTek Unveils The CUBE V3 Portable, Plug and Play Interactive Projection Display System for Advertising and Exhibits 2Air Force Center of Excellence awarded in nanostructures and improved cognition 2Air Force Center of Excellence awarded in nanostructures and improved cognition 3Air Force Center of Excellence awarded in nanostructures and improved cognition 4EUCODIS Bioscience Appoints Bhupinder Hundle to Senior Vice President Marketing 26amp 3B Sales 5378 1EUCODIS Bioscience Appoints Bhupinder Hundle to Senior Vice President Marketing 26amp 3B Sales 5378 2EUCODIS Bioscience Appoints Bhupinder Hundle to Senior Vice President Marketing 26amp 3B Sales 5378 3A Little Cash Buys a Lot of Calories at the Corner Store 59282 1A Little Cash Buys a Lot of Calories at the Corner Store 59282 2Proteolix Inc to be Acquired By Onyx Pharmaceuticals 59278 1Proteolix Inc to be Acquired By Onyx Pharmaceuticals 59278 2Proteolix Inc to be Acquired By Onyx Pharmaceuticals 59278 3Proteolix Inc to be Acquired By Onyx Pharmaceuticals 59278 4... in the Arctic has shrunk to its lowest level this... years ago, opening up the Northwest Passage a lo...as been historically impassable. , In the mosaic ...ed in early September 2007 by the Advanced Synthet...visat satellite, the dark gray colour represents t...
..., 2007 One of the 2007 American Society for Microb...ored by ASM will be presented to Hung Ton-That, Ph...cular, Microbial, and Structural Biology, Universi...being honored for his research excellence in micro... research is highly regarded, and has been publish...
...ale skeleton excavated 20 years ago amid the stenc... on California,s A o Nuevo Island turns out to be ...sil whale fall and the first in California, accord...ologists. , Whale falls, first recognized in the ...cean floor where, like an oasis in the desert, the...
Other Biology News:Satellites witness lowest Arctic ice coverage in history 2Ancient whale fall from California's Ao Nuevo Island one of youngest, most complete known 2Ancient whale fall from California's Ao Nuevo Island one of youngest, most complete known 3(Date:12/1/2009)... PDL BioPharma, Inc. (PDL...e for the fourth quarter ended December 31, 2009 o...million for the fourth quarter of 2008. Included i... installment payments of $12.5 million from Alexio...as a one-time $1.8 million payment from Genentech ...
(Date:12/1/2009)... 1 To address the emergence of the...ential, a group of individuals and companies annou...ry Association (SynBIA) in Cambridge, Massachusett...vide a forum for individuals and commercial intere...tunities and its challenges, and advocate for its ...
(Date:12/1/2009)...wire/ -- The Burrill Biotech Select Index managed ...ber. The Select,s gain of 4.5 percent mirrored wha...ets with the Dow up 6.5 percent and the NASDAQ up ...inal two trading days of the month despite investo...ping and Dubai,s reported debt woes. ,, Almost ...
(Date:12/1/2009)...RNewswire-FirstCall/ -- Aethlon Medical, Inc. (OTC...l present at the LD MICRO Conference on Thursday, ...tel in Los Angeles. Aethlon Medical,s Chairman and...rview and will provide an update on the company,s ...rifier®, a first-in-class artificial adjunct ...
Breaking Biology Technology:PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 2PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 3Industry Forms Association to Address Opportunities and Challenges of Synthetic Biology 2Biotech Gets Back on Track in November 2Biotech Gets Back on Track in November 3Biotech Gets Back on Track in November 4Aethlon Medical to Present at LD MICRO Conference on December 3, 2009 2...ion with Kentucky Bioprocessing for future-oriente...Ky., Sept. 29 Bayer,Innovation GmbH and Kentucky ...lop a facility at KBP,s Owensboro plant in the US ...opharmaceuticals. Based on Bayer,s proprietary,mag...teins (PMP) and other,high-value products will be ...
... Sept. 29 Cell Therapeutics, Inc.,("CTI" or the "...nounced that,a single institutional investor shall...onvertible Senior Notes due 2012, with a conversio... result of an amendment of a,September 15, 2008 ag...hich,the investor had purchased $9 million of seni...
...S, Md., Sept. 26 PharmAthene, Inc.,(Amex: PIP ),...asures,against biological and chemical threats, an...gy and Infectious Diseases (NIAID), part of the Na... Company a multi-year contract,for up to $83.9 mil...n,recombinant protective antigen (rPA) anthrax vac...
Other Biology Technology:Bayer Broadens Its Manufacturing Basis for Biopharmaceuticals in Tobacco Plants 2Bayer Broadens Its Manufacturing Basis for Biopharmaceuticals in Tobacco Plants 3Bayer Broadens Its Manufacturing Basis for Biopharmaceuticals in Tobacco Plants 4Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $14.2 Million of Senior Convertible Notes 2Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $14.2 Million of Senior Convertible Notes 3PharmAthene Awarded NIAID Contract For Up to $83.9 Million For Third Generation rPA Anthrax Vaccine Program 2PharmAthene Awarded NIAID Contract For Up to $83.9 Million For Third Generation rPA Anthrax Vaccine Program 3PharmAthene Awarded NIAID Contract For Up to $83.9 Million For Third Generation rPA Anthrax Vaccine Program 4PharmAthene Awarded NIAID Contract For Up to $83.9 Million For Third Generation rPA Anthrax Vaccine Program 5PharmAthene Awarded NIAID Contract For Up to $83.9 Million For Third Generation rPA Anthrax Vaccine Program 6Mouse Anti-Bacteria RNA polymerase sigma 70 Monoclonal Antibody, Unconjugated, Clone 2G10 from ABR-Affinity BioReagents
Rat Anti-UGGT Monoclonal Antibody, Unconjugated from Abcam
LC/MSD TOF from Agilent Technologies
Mouse Anti-Human LAT, phospho (Tyr226) Monoclonal Antibody, Unconjugated, Clone J96-1238.58.93 from BD Biosciences Pharmingen
Biology Products: